The combined PCK1 and PCK2 score was significantly elevated in NSCLC metastases compared to primary cancers, while the glycolysis marker GLUT1 showed no differential expression in metastases versus primary tumors. The gene discussed is PCK1; the disease is non-small cell lung carcinoma.